Cargando…

Inactivation of Zika Virus by Photoactive Iodonaphthyl Azide Preserves Immunogenic Potential of the Virus

Zika virus’s (ZIKV) emergence as a pathogen of significant public health importance has accelerated efforts to develop a ZIKV vaccine. To date, the need for an effective ZIKV vaccine is unmet. In this study, we report inactivation of ZIKV using a hydrophobic photoactive compound: 1, 5 iodonaphthyl a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Austin, Amy L., Galasso, Bianca, Nickens, Caitlin, Knollmann-Ritschel, Barbara, Sharma, Anuj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963691/ https://www.ncbi.nlm.nih.gov/pubmed/31614887 http://dx.doi.org/10.3390/pathogens8040188

Ejemplares similares

Inactivation of non-enveloped virus by 1,5 iodonaphthyl azide
por: Gupta, Paridhi, et al.
Publicado: (2015)

Educational Case: Hepatitis B Virus
por: Nickens, Caitlin M., et al.
Publicado: (2019)

Inactivation of Chikungunya virus by 1,5 iodonapthyl azide
por: Sharma, Anuj, et al.
Publicado: (2012)

Educational Case: Nutrient Deprivation and Anemia
por: Nickens, Caitlin, et al.
Publicado: (2019)

Magnetic bead purification of enveloped alphavirus and flavivirus
por: Galasso, Bianca, et al.
Publicado: (2021)

Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development
por: Sharma, Anuj, et al.
Publicado: (2019)

Inactivation and Environmental Stability of Zika Virus
por: Müller, Janis A., et al.
Publicado: (2016)

Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus
por: Gupta, Paridhi, et al.
Publicado: (2017)

Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice
por: To, Albert, et al.
Publicado: (2018)

ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection
por: Tebas, Pablo, et al.
Publicado: (2017)

Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
por: Tanelus, Manette, et al.
Publicado: (2023)

Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection
por: Acosta, Camilo J, et al.
Publicado: (2022)

Safety and immunogenicity of Zika virus vaccine: A systematic review of clinical trials
por: Yeasmin, Mahmuda, et al.
Publicado: (2022)

A virus preservation solution that inactivates the virus while maintaining the virus particle intact
por: Weng, Yuesong, et al.
Publicado: (2022)

An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques
por: Lecouturier, Valérie, et al.
Publicado: (2020)

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures
por: Geeraedts, Felix, et al.
Publicado: (2010)

Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika Virus
por: Batista, Mariana N., et al.
Publicado: (2019)

Effects of Sodium Azide on the Abundance of Prokaryotes and Viruses in Marine Samples
por: Winter, Christian, et al.
Publicado: (2012)

Zika Virus
por: Masmejan, Sophie, et al.
Publicado: (2020)

Photoactive Nanomaterials
por: Nuraje, Nurxat
Publicado: (2021)

Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity
por: Dinnon III, Kenneth H., et al.
Publicado: (2019)

Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets
por: Kim, In-Jeong, et al.
Publicado: (2022)

Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus
por: Steffen, Tara, et al.
Publicado: (2020)

Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine
por: Wang, Xinyi, et al.
Publicado: (2019)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
por: López-Camacho, César, et al.
Publicado: (2019)

Influence of Dosing Regimen and Adjuvant Type on the Immunogenicity of Novel Recombinant Zika Virus-Like Particles
por: Brzuska, Gabriela, et al.
Publicado: (2022)

A Peptide-Based Virus Inactivator Protects Male Mice Against Zika Virus-Induced Damage of Testicular Tissue
por: Si, Lulu, et al.
Publicado: (2019)

Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine
por: Lima, Noemia S., et al.
Publicado: (2021)

A minimally manipulated preservation and virus inactivation method for amnion/chorion
por: Zhang, Shang, et al.
Publicado: (2022)

Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway
por: He, Miao, et al.
Publicado: (2018)

A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses
por: Yu, Yufeng, et al.
Publicado: (2017)

Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator
por: Wang, Xiaohuan, et al.
Publicado: (2019)

Etymologia: Zika Virus
Publicado: (2014)

Zika virus: An overview
por: Rawal, Gautam, et al.
Publicado: (2016)

The immunology of Zika Virus
por: Culshaw, Abigail, et al.
Publicado: (2018)

Zika Virus Disease
por: Al-Afaleq, Adel I.
Publicado: (2017)

Emerging Zika virus
por: Yasri, Sora, et al.
Publicado: (2016)

Zika virus infection
por: Werner Jr., Heron
Publicado: (2019)

An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens
por: Jin, Hongli, et al.
Publicado: (2021)

Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice
por: Liu, Xiaohui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1a5poib096maap0a2bot2g7r3t